A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat Read more about A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants Read more about Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention Read more about Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention
Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine Read more about Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
A Study of Acute Respiratory Infections in Global Outpatient Setting Read more about A Study of Acute Respiratory Infections in Global Outpatient Setting
A Study of Bemarituzumab Monotherapy and Docetaxel Combination in Participants With Squamous Non-small-cell Lung Cancer (SqNSCLC) With Fibroblast Growth Factor Receptor Isoform 2b (FGFR2b) Overexpression Read more about A Study of Bemarituzumab Monotherapy and Docetaxel Combination in Participants With Squamous Non-small-cell Lung Cancer (SqNSCLC) With Fibroblast Growth Factor Receptor Isoform 2b (FGFR2b) Overexpression
Updated Diagnostic Cortisol Values for Adrenal Insufficiency Read more about Updated Diagnostic Cortisol Values for Adrenal Insufficiency
A Trial of TTI-622 in Patients With Advanced Hematologic Malignancies Read more about A Trial of TTI-622 in Patients With Advanced Hematologic Malignancies
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer Read more about Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer Read more about Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer